Analysis of the factor V Leiden mutation using the READIT Assay

Citation
Rb. Rhodes et al., Analysis of the factor V Leiden mutation using the READIT Assay, MOL DIAGN, 6(1), 2001, pp. 55-61
Citations number
12
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
MOLECULAR DIAGNOSIS
ISSN journal
10848592 → ACNP
Volume
6
Issue
1
Year of publication
2001
Pages
55 - 61
Database
ISI
SICI code
1084-8592(200103)6:1<55:AOTFVL>2.0.ZU;2-A
Abstract
Background: A variety of methods exist for the detection of single-nucleoti de polymorphisms (SNPs) present in amplified segments of genomic DNA. We sh ow the application of a novel SNP scoring tool for analysis of the factor V Leiden mutation. Methods and Results: We have developed a novel method for analyzing SNPs. T he luciferase-based technique, known as the READIT Technology (Promega Corp , Madison, WI), was used to analyze 510 residual human samples sent for fac tor V Leiden testing from three independent testing laboratories. A blinded retrospective analysis of the factor V Leiden mutation was used to determi ne the accuracy and throughput capabilities of the technology. One hundred percent concordance was observed between the READIT Assay and genotype assi gnments made in the testing laboratories. In addition, greater than 6 SDs o f separation were observed between the means of wild-type and heterozygote sample populations. Repetitive sample measurements with representative wild -type, heterozygote, and mutant samples showed that greater than 9 SDs sepa rated the means of heterozygote and homozygote sample populations. Confiden ce intervals based on the means of wild-type, heterozygote, and mutant samp le populations were determined. Conclusion: perfect concordance using the READIT Assay showed its effective ness as a SNP scoring tool. The design of the factor V READIT Assay was str aightforward, requiring the design of two unmodified oligonucleotides that differ at the 3' penultimate position to form perfect hybrids with the wild -type or Leiden form of the factor V sequence. The use of previously publis hed amplification primers and conditions minimized the time needed to optim ize and validate the assay. The READIT Calculator supplied with the assay a llowed automated genotype assignments and statistical analysis from the REA DIT Assay data. Confidence-interval analysis validated the ability to disti nguish between wild-type, heterozygote, and mutant samples using the READIT Assay.